Breaking News Instant updates and real-time market news.

SNN

Smith & Nephew

$35.84

0.5 (1.41%)

08:02
02/15/18
02/15
08:02
02/15/18
08:02

Smith & Nephew announces data from ALLEVYN LIFE trial

Smith & Nephew announces the publication of a randomised controlled trial demonstrating that the addition of ALLEVYN LIFE, Smith & Nephew's leading multi-layer silicone adhesive foam dressing, to a standard care protocol significantly reduces the onset of pressure ulcers by 71% in elderly patients admitted to hospital for hip fracture. Published in the International Wound Journal, the RCT charts the experience of 359 fragile hip fracture patients aged 65 or over. These patients were randomly divided into two groups, with some receiving standard care and others receiving standard care with the addition of an ALLEVYN LIFE dressing applied to the sacrum. 15.4% of patients receiving standard care developed a pressure ulcer as opposed to only 4.5% of the group who received the same care with the addition of ALLEVYN LIFE resulting in a 71% reduction in pressure ulcer incidence. This new study adds to the growing body of evidence demonstrating the effectiveness of ALLEVYN LIFE in multi-component pressure ulcer prevention programmes1-5. Prophylactic dressings do not negate the need for thorough and regular skin assessment and should be used as part of a comprehensive pressure ulcer prevention protocol. ALLEVYN LIFE has been designed following observational ethnographic research with patients and clinicians to address unmet needs in wound management. The dressing has a five layer design incorporating a breathable top layer, hydrocellular foam, hyper-absorbent lock away core, masking layer, silicone gel adhesive layer and wide border. ALLEVYN LIFE Sacrum has a unique tail designed specifically for wounds in the sacral area and fits around the cleft, to help overcome common problems such as the dressing tenting.

SNN Smith & Nephew
$35.84

0.5 (1.41%)

03/21/17
03/21/17
UPGRADE
Target $36

Buy
Wright Medical upgraded on increased likelihood of a takeout at Northcoast
As previously reported, Northcoast upgraded Wright Medical (WMGI) to Buy from Neutral with a $36 price target. Analyst David Kaiser said he has been slow to appreciate Wright's competitive advantages in the extremity market and believes a takeout is increasingly likely in 2017. The analyst attended last week's American Academy of Orthopedic Surgeons annual meeting and said multiple private industry contacts told him there is increased speculation in the market about one of the four major joint replacement manufacturers acquiring Wright Medical soon. Kaiser believes Smith & Nephew (SNN) is the most logical acquirer given it has virtually no presence in the extremity market, has a very strong balance sheet, and a clear strategy to shift its business mix to faster-growing areas.
10/11/17
ADAM
10/11/17
INITIATION
Target $42
ADAM
Buy
Smith & Nephew initiated with a Buy at Canaccord
Canaccord analyst Kyle rose initiated Smith & Nephew with a Buy as he believes its broad product portfolio provides a stronger foundation from which the company can realize accelerating top-line growth. He said its recent restructuring has positioned it to focus on commercial execution and operating leverage. Rose has a $42 price target on Smith & Nephew shares.
12/11/17
MSCO
12/11/17
DOWNGRADE
MSCO
Equal Weight
Smith & Nephew downgraded to Equal Weight from Overweight at Morgan Stanley
01/25/18
JPMS
01/25/18
UPGRADE
JPMS
Overweight
Smith & Nephew upgraded to Overweight from Neutral at JPMorgan
JPMorgan analyst David Adlington upgraded Smith & Nephew to Overweight and raised his price target for the shares to GBP 14.11 from GBP 13.69.

TODAY'S FREE FLY STORIES

PZZA

Papa John's

$47.10

-0.2 (-0.42%)

15:41
03/19/19
03/19
15:41
03/19/19
15:41
Periodicals
Breaking Periodicals news story on Papa John's »

Hedgeye adds Papa…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

  • 20

    Mar

PVTL

Pivotal Software

$20.01

0.33 (1.68%)

15:38
03/19/19
03/19
15:38
03/19/19
15:38
Conference/Events
Pivotal Software management to meet with UBS »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Mar

RTIX

RTI Surgical

$5.92

-0.04 (-0.67%)

15:38
03/19/19
03/19
15:38
03/19/19
15:38
Hot Stocks
Glen Capital Partners reports 7.09% passive stake in RTI Surgical »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Apr

  • 28

    May

NAV

Navistar

$32.95

0.26 (0.80%)

15:37
03/19/19
03/19
15:37
03/19/19
15:37
Conference/Events
Navistar management to meet with UBS »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Mar

AUPH

Aurinia Pharmaceuticals

$6.44

0.17 (2.71%)

15:34
03/19/19
03/19
15:34
03/19/19
15:34
Options
Aurinia Pharmaceuticals options imply 15.8% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

FB

Facebook

$161.69

1.23 (0.77%)

15:32
03/19/19
03/19
15:32
03/19/19
15:32
Hot Stocks
Facebook settles discriminatory advertising lawsuits »

Facebook COO Sheryl…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Mar

  • 04

    Apr

LXRX

Lexicon

$7.79

0.18 (2.37%)

15:30
03/19/19
03/19
15:30
03/19/19
15:30
Options
Call buyer opens a bullish position in Lexicon Pharmaceuticals upside calls »

Call buyer opens a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Mar

  • 25

    Apr

HRTX

Heron Therapeutics

$24.70

0.28 (1.15%)

15:20
03/19/19
03/19
15:20
03/19/19
15:20
Options
6X average daily option volume in Heron Therapeautics driven by call spreads »

6X average daily option…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Apr

HNP

Huaneng Power

$23.42

-0.47 (-1.97%)

15:19
03/19/19
03/19
15:19
03/19/19
15:19
Downgrade
Huaneng Power rating change  »

Huaneng Power downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SMAR

Smartsheet

$43.88

0.21 (0.48%)

15:19
03/19/19
03/19
15:19
03/19/19
15:19
Options
Smartsheet options imply 12.4% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

  • 05

    Apr

VALE

Vale

$13.90

0.62 (4.67%)

15:18
03/19/19
03/19
15:18
03/19/19
15:18
Hot Stocks
Vale reports reestablishment of Guaiba Island Terminal activities »

In a regulatory filing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Mar

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

15:17
03/19/19
03/19
15:17
03/19/19
15:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

15:16
03/19/19
03/19
15:16
03/19/19
15:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MNK

Mallinckrodt

$23.24

0.54 (2.38%)

15:10
03/19/19
03/19
15:10
03/19/19
15:10
Conference/Events
Mallinckrodt management to meet with Mizuho »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Mar

SYMC

Symantec

$23.27

0.19 (0.82%)

15:10
03/19/19
03/19
15:10
03/19/19
15:10
Options
Put buyers sizing up new positions in Symantec far downside strikes »

Put buyers sizing up new…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Apr

GATX

GATX

$76.90

0.21 (0.27%)

15:08
03/19/19
03/19
15:08
03/19/19
15:08
Conference/Events
GATX management to meet with Mizuho »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

  • 26

    Mar

BA

Boeing

$375.00

2.9 (0.78%)

15:08
03/19/19
03/19
15:08
03/19/19
15:08
Periodicals
DOT asks department watchdog to audit approval of Boeing 737, Bloomberg says »

Transportation Secretary…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

  • 28

    May

BA

Boeing

$375.07

2.97 (0.80%)

15:05
03/19/19
03/19
15:05
03/19/19
15:05
Periodicals
Breaking Periodicals news story on Boeing »

DOT asks Inspector…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

  • 28

    May

TME

Tencent Music

$19.33

0.2 (1.05%)

15:04
03/19/19
03/19
15:04
03/19/19
15:04
Options
Tencent options imply 12.9% move in share price post-earnings »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

NAII

Natural Alternatives International

$11.20

-0.17 (-1.50%)

15:01
03/19/19
03/19
15:01
03/19/19
15:01
Hot Stocks
Natural Alternatives says Court of Appeals rules in its favor in patent suit »

Natural Alternatives…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

15:00
03/19/19
03/19
15:00
03/19/19
15:00
General news
Treasury Closing Summary: »

Treasury Closing Summary:…

KEM

Kemet

$18.34

0.02 (0.11%)

14:56
03/19/19
03/19
14:56
03/19/19
14:56
Conference/Events
Kemet management to meet with B. Riley FBR »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

DBD

Diebold

$11.07

-0.33 (-2.89%)

14:55
03/19/19
03/19
14:55
03/19/19
14:55
Options
Diebold put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMD

AMD

$25.68

2.43 (10.45%)

, GOOG

Alphabet

$1,195.81

12.15 (1.03%)

14:54
03/19/19
03/19
14:54
03/19/19
14:54
Hot Stocks
AMD says Radeon GPUs being used for Google Stadia platform »

AMD (AMD) announced that…

AMD

AMD

$25.68

2.43 (10.45%)

GOOG

Alphabet

$1,195.81

12.15 (1.03%)

GOOGL

Alphabet Class A

$1,199.72

11.63 (0.98%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Mar

  • 04

    Apr

  • 29

    Apr

  • 29

    Apr

  • 27

    Oct

SIEN

Sientra

$9.26

0.05 (0.54%)

14:51
03/19/19
03/19
14:51
03/19/19
14:51
Hot Stocks
Breaking Hot Stocks news story on Sientra »

Sientra down 6% after FDA…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.